Loading...
Molecular determinants of response to high-dose androgen therapy in prostate cancer
Clinical trials of high-dose androgen (HDA) therapy for prostate cancer (PC) have shown promising efficacy but are limited by lack of criteria to identify likely responders. To elucidate factors that govern the growth-repressive effects of HDAs, we applied an unbiased integrative approach using gene...
Na minha lista:
| Udgivet i: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6795499/ https://ncbi.nlm.nih.gov/pubmed/31503550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.129715 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|